Vaccines
Vaccine programs move on tight timelines, and your plan needs to keep up
Regulatory paths, recruitment, and fast-moving pathogens can slow a program down. Our scientists help you see the risks early and keep your vaccine moving toward approval.
Vaccine Development CRO and Regulatory Partner
Accelerate your vaccine development with scientific clinical development expertise
Vaccine developers worldwide face a complex challenge: advancing their vaccines safely and quickly through the clinical development and approval process to prevent millions of deaths every year. Vaccines are crucial to prevent or treat cancers, viral, and bacterial infections, and rapidly respond to infectious disease pandemics like Ebola, MERS, and most recently, COVID-19.
To help sponsors develop best-in-class vaccines that improve the length and quality of patients' lives, Veristat has assembled an extraordinary team of scientific experts to design, build, and run your clinical program. Having planned and executed more than 55 vaccine clinical trials and consulting projects in the past 5 years, our teams navigate regulatory complexities, overcome recruitment challenges, and streamline the approval process to bring safe, effective vaccines to market.
55+
vaccine trials and consulting projects in the past 5 years
Types of Vaccines Supported by Veristat
From infectious disease outbreaks to oncology, our team brings hands-on clinical development experience across the vaccine landscape. Here's where that experience runs deepest.
Infectious Disease Vaccines
Whether responding to an emerging pathogen or advancing a well-established target, we've supported vaccine programs across a range of infectious diseases, including:
- Coronaviruses (SARS-CoV-1, SARS-CoV-2, and MERS-CoV)
- Ebola
- Herpes Simplex Virus (HSV)
- Influenza — Seasonal & Pandemic
- Respiratory Syncytial Virus (RSV)
- Varicella-Zoster Virus (VZV)
Cancer Vaccines
Our team also brings experience to vaccines designed to prevent or treat cancer, spanning a range of tumor types, including:
- Breast Cancer
- Head & Neck Cancer
- Melanoma
- Ovarian Cancer
- Renal Cancer
- Solid Tumors — AI powered
Why Veristat
Our scientific experts bring your vaccine to market rapidly with:
No matter what stands in your way, our highly qualified regulatory and clinical development experts provide creative, strategic, and agile approaches to tackle the most complex challenges in program design, clinical trial conduct, and the regulatory approval process. If you're looking for full-service clinical trial solutions, support for a single service, regulatory or strategic advice, or need specific experts to augment your in-house resources, Veristat can help.
Regulatory Strategy
Development of regulatory strategy, expedited pathways, and regulatory agency interactions.
Clinical Program Planning
Statistical planning and analysis built into every program design.
Patient Recruitment
Agile strategies that support virtual trial and hybrid approaches.
Clinical Trial Databases
Rapid deployment to keep your program moving.
Site Monitoring
Virtual and remote clinical and medical site monitoring.
Data Management
Data analysis and migration into CDISC formats.
Regulatory and Safety Writing
Clinical trial, safety, and regulatory documentation.
Marketing Applications
Preparation and defense of NDAs, BLAs, NDSs, MAAs, jNDAs, and more.
“We thank the entire Veristat team, who has worked so diligently. We are gratified to know that the efforts and commitment of Veristat has resulted in an approved vaccine to advance protection against the virus.”
— Spanish Pharmaceutical Company
PROOF POINTS
What our vaccine experience looks like in numbers
55+
vaccine trials and consulting projects.
70%+
of Veristat clinical trial teams have supported vaccine trials
PROOF & RESOURCES
Real Programs, Real Outcomes
A Practical Guide for Managing Multiple Global Regulatory Pathways
Learn More →
FDA Expedited Programs – What You Need to Know
Learn More →
Side-by-Side Comparison: Non-Adaptive vs. Adaptive Designs in ...
Learn More →
Tell us where your vaccine program stands
Whether you're developing a vaccine to treat cancer or respond to an infectious disease outbreak like COVID-19, we tackle the complexities of testing immunotherapy, viral, and DNA vaccines. We've assembled a team of scientific experts who understand the unknowns of vaccine development, helping sponsors succeed in extending and saving lives.
